The effect of continuous positive airway pressure on metabolic variables in patients with obstructive sleep apnoea

Chronic Respiratory Disease

Volumn 11, Issue 1, 2014, Pages 41-52

  Schlatzer, Christian ^a   Schwarz, Esther I ^a   Kohler, Malcolm ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

adipokines; continuous positive airway pressure (CPAP); diabetes mellitus; fat distribution; lipids; metabolic syndrome; Obstructive sleep apnoea (OSA)

Indexed keywords

ADIPOCYTOKINE; FAT; GLUCOSE; INSULIN; LIPID;

ARTICLE; BODY FAT DISTRIBUTION; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDERED BREATHING; THERAPY EFFECT;

ADIPOKINES; CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP); DIABETES MELLITUS; FAT DISTRIBUTION; LIPIDS; METABOLIC SYNDROME; OBSTRUCTIVE SLEEP APNOEA (OSA);

ADIPOKINES; BODY FAT DISTRIBUTION; CONTINUOUS POSITIVE AIRWAY PRESSURE; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84892732894     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972313516882     Document Type: Article

References (45)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med. 1993 ; 328: 1230-1235
2. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006 ; 61: 945-950
3. Bonsignore MR, Esquinas C, Barcelo A, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2012 ; 39: 1136-1143
4. Clarenbach CF, West SD, Kohler M. Is obstructive sleep apnea a risk factor for diabetes?. Discov Med. 2011 ; 12: 17-24
5. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet. 1999 ; 353: 2100-2105
6. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002 ; 359: 204-210
7. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med. 2011 ; 184: 1192-1199
8. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004 ; 169: 156-162
9. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Resp: Int Rev Thor Dis. 2004 ; 71: 252-259
10. Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008 ; 134: 686-692
11. Barcelo A, Barbe F, de la Pena M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax. 2008 ; 63: 946-950
12. Carneiro G, Togeiro SM, Ribeiro-Filho FF, et al. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord. 2009 ; 7: 537-542
13. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab. 2007 ; 9: 679-687
14. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008 ; 38: 585-595
15. Garcia JM, Sharafkhaneh H, Hirshkowitz M, et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011 ; 12: 80
16. Dawson A, Abel SL, Loving RT, et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med. 2008 ; 4: 538-542
17. Shpirer I, Rapoport MJ, Stav D, et al. Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath. 2012 ; 16: 461-466
18. Myhill PC, Davis WA, Peters KE, et al. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab. 2012 ; 97: 4212-4218
19. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007 ; 62: 969-974
20. Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung. 2009 ; 187: 17-22
21. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007 ; 29: 720-727
22. Hoyos CM, Killick R, Yee BJ, et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012 ; 67: 1081-1089
23. Lam JC, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010 ; 35: 138-145
24. Nguyen PK, Katikireddy CK, McConnell MV, et al. Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson. 2010 ; 12: 50
25. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. New Engl J Med. 2011 ; 365: 2277-2286
26. Sivam S, Phillips CL, Trenell MI, et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J. 2012 ; 40: 913-918
27. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012 ; 35: 617-625B
28. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000 ; 23: 57-63
29. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabetic Med. 2002 ; 19: 527-534
30. Cuhadaroǧlu C, Utkusavas A, Ozturk L, et al. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009 ; 187: 75-81
31. Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007 ; 132: 843-851
32. Kawano Y, Tamura A, Kadota J. Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol. Metabolism. 2012 ; 61: 186-192
33. Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial. Am J Respir Crit Care Med. 2011 ; 184: 355-361
34. Robinson GV, Pepperell JC, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004 ; 59: 777-782
35. Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004 ; 24: 29-33
36. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002 ; 13: 134-141
37. Gautron L, Elmquist JK. Sixteen years and counting: an update on leptin in energy balance. J Clin Invest. 2011 ; 121: 2087-2093
38. de Lima AM, Franco CM, de Castro CM, et al. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respir: Int Rev Thoracic Dis. 2010 ; 79: 370-376
39. Harsch IA, Wallaschofski H, Koebnick C, et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respir: Int Rev Thoracic Dis. 2004 ; 71: 580-586
40. Drummond M, Winck JC, Guimaraes JT, et al. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med. 2008 ; 8: 21
41. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003 ; 22: 251-257
42. Kohler M, Ayers L, Pepperell JC, et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax. 2009 ; 64: 67-73
43. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999 ; 100: 706-712
44. Kritikou I, Basta M, Tappouni R, et al. Sleep apnoea and visceral adiposity in middle-aged male and female subjects. Eur Respir J. 2013 ; 41: 601-609
45. West SD, Kohler M, Nicoll DJ, Stradling JR. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med. 2009 ; 10: 1056-1058